Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
KK Pharma,Inc. logo
4896TSE Growth

K Pharma,Inc.

ケイファーマ Yahoo Finance

Recent & upcoming events

Aug 13
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar
May 14
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Mar 25
Shareholder meeting 21:00
Shareholders' meeting
Venue: 東京都港区赤坂九丁目7番1号 Details
Add to Google Calendar
Feb 12
Earnings 1:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 12
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
2027
Feb 11
Est.
Earnings 1:00 approx.
Full-year earnings
Add to Google Calendar
May 13
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar
Aug 12
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar

KPI highlights

FY25
Revenue ¥0 YoY —
Operating income ¥-916M
Net income ¥-993M YoY —
EPS —
P/E —
ROE —

Company guidance

FY2026/12 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue — —
Operating income ¥-1.52B —
Net income ¥-1.62B —
EPS ¥-139 —

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q1FY26 Q1
Revenue ¥0¥0¥0¥0——
Operating income ¥-135M¥-150M¥-231M¥-193M——
Net income ¥-117M¥-138M¥-233M¥-193M——
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2023–2025）

事業法人 17.6%国内機関 18.2%個人 40.9%未開示 23.3%202320242025
事業法人国内機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

福島　弘明 20.1%福島　弘明SBI Ventures Two株式 14.9%SBI Ventures Two株式会社中村　雅也 10.1%中村　雅也岡野　栄之 10%岡野　栄之大和日台バイオベンチャー２号投資事業 9.8%大和日台バイオベンチャー２号投資事業有限責任組合かごしまバリューアップ投資事業有限責 5.5%かごしまバリューアップ投資事業有限責任組合アルフレッサホールディングス株式会社 2.7%アルフレッサホールディングス株式会社テクノロジーベンチャーズ５号投資事業 2%テクノロジーベンチャーズ５号投資事業有限責任組合202320242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
福島 弘明 2,331,000 20.1% Yuho (EDINET)
SBI Ventures Two株式会社 1,726,500 14.9% Yuho (EDINET)
中村 雅也 1,177,000 10.1% Yuho (EDINET)
岡野 栄之 1,166,000 10.0% Yuho (EDINET)
大和日台バイオベンチャー2号投資事業有限責任組合 1,143,000 9.8% Yuho (EDINET)
かごしまバリューアップ投資事業有限責任組合 641,000 5.5% Yuho (EDINET)
アルフレッサホールディングス株式会社 315,700 2.7% Yuho (EDINET)
テクノロジーベンチャーズ5号投資事業有限責任組合 234,800 2.0% Yuho (EDINET)
モルガン・スタンレーMUFG証券株式会社 99,600 0.9% Yuho (EDINET)
吉田 勝則 80,000 0.7% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

2/9 2 of 9 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✗ Positive ROA ROA -33.8%
✗ Positive operating cash flow ¥-987M
✓ ROA improved YoY -36.0% → -33.8%
✓ Operating CF exceeds net income (accrual quality) OCF ¥-987M / net income ¥-993M
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 96.0% → 43.1%
— Current ratio improved No data
✗ No dilution (shares outstanding did not increase) 11,604,600 → 11,609,600
— Gross margin improved No data
✗ Asset turnover improved 0.00× → 0.00×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio —
Current ratio —
Years of positive operating CF 1 of last 5 yrs
Payout ratio 0%
Latest fiscal year result Loss (net loss ¥993M)

Performance history

Last 10 years
0億円3億円5億円8億円10億円 FY21FY22FY23FY24FY25

Income & assets

Unit: ¥100M
Item FY21FY22FY23FY24FY25
Revenue 0.000.0010.00.000.00
Operating income -2.19-3.543.66-8.36-9.16
Ordinary income ——3.44-8.36-9.21
Net income -2.29-3.922.60-8.46-9.93
Total assets 2.0613.733.123.529.4
Equity 1.7913.431.022.612.7

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: ¥100M
Item FY21FY22FY23FY24FY25
EPS ¥-20¥-42¥23¥-73—
ROE -127.9%-29.4%———
Operating CF -2.11-4.024.11-9.49-9.87
Investing CF 0.00-0.33-0.11-0.14-0.55
Financing CF 3.6815.414.90.0015.0
FCF -1.96-3.934.45-9.98-9.29

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data